Skip to main content
. Author manuscript; available in PMC: 2012 Oct 1.
Published in final edited form as: J Inherit Metab Dis. 2011 May 10;34(5):1075–1081. doi: 10.1007/s10545-011-9346-0

Table 1.

Demographic data on genetically confirmed JNCL subjects whose parents completed the survey on flupirtine use. Age of subject at survey completion excluded one subject who was deceased at time of survey

Have taken flupirtine Never taken flupirtine
JNCL subjects (n) 9 33
Sex (F/M) 3/6 15/18
Mean (SD) age at survey completion (years) 15.0 (5.2) 17.3 (4.7)
Genotype: homozygous for common deletion (n) 8 22
Genotype: compound heterozygous (n) 1 11